Voloridge Investment Management, LLC Bria Cell Therapeutics Corp. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.28 - $11.9 $64,889 - $180,415
-15,161 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.91 - $10.14 $1.11 Million - $1.91 Million
-188,205 Reduced 92.54%
15,161 $154,000
Q4 2021

Feb 14, 2022
BUY
$7.1 - $10.61 $329,582 - $492,516
46,420 Added 29.58%
203,366 $1.68 Million
Q3 2021

Nov 15, 2021
BUY
$4.4 - $9.28 $690,562 - $1.46 Million
156,946 New
156,946 $1.27 Million

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $5.9M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email